Patients as Partners – putting people first in clinical trials
June 28, 2023 | Patient-centricity, clinical trials, patient engagement
Cuttsy+Cuttsy’s key takeaways from the Patients as Partners conference 2023
Recently, Cuttsy+Cuttsy attended Patients as Partners, Europe 2023 in London. It’s an event that looks at how greater patient involvement can increase efficiency in clinical research and improve outcomes for everyone. With a packed agenda discussing the importance of working with patients, here are their key takeaways from the event.
Mental health really matters
The mental health and wellbeing of patients participating in clinical trials was a key focus and talking point throughout the conference.
Patients may already have a lot to contend with, not just in terms of their medical condition, but with the challenges of life in general. Participating in a clinical trial can add to their concerns. Additional physical and physiological symptoms as well as potential logistical or financial challenges can place an extra burden on a patient’s wellbeing. This can impair their ability to process and understand important information about the trial. Failure to take such issues into account can be a risk to their continued participation.
Understand diverse needs
Designing clinical trials to include representative groups is widely acknowledged. But engaging different communities requires a deeper understanding of motivations, concerns and the level of trust in the healthcare system. For example, the concerns of a trans person from the LGBTQI+ community about how they may be treated on a trial will be different to someone from a South Asian community apprehensive about whether to put their trust in experts outside of their network, and different again to those of someone living with a physical disability. Everyone should have access to the right treatments, but if recruitment efforts do not address the issues relevant to different communities, then we risk significant segments of society not being involved in the development of treatments.
3-step approach
So, how can you ensure a more consistent approach to patient engagement and participation in clinical studies? At Cuttsy+Cuttsy, we’d recommend a 3-step approach to improve patient engagement, experience and outcomes:
- Research: Ideally, at the trial design stage — or even earlier — take the time to really understand the patient population. Meet real people, ask questions, get them involved with the trial design and discover uncomfortable truths that might stop potential participants from taking part. One size most certainly doesn’t fit all, and without research, there’s a risk whole communities may feel excluded
- Co-creation: It’s not enough to review data and consider the patient’s point of view. To engage patients and keep them connected, involve them and ask for feedback as partners, every step of the way
- Health literacy: It’s about more than words or making healthcare comms easy to understand. For patients from diverse communities, it’s about considering perceptions, the use of language and how information is received and acted upon
Adopting this approach with your next clinical trial will undoubtedly help improve recruitment and retention rates but, most importantly, you’ll be well on your way to truly working with ‘Patients as Partners’.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
The outcomes are already chosen. So when can patients really shape them?
Explore why involving patients early in Joint Scientific Consultations is critical to shaping the outcomes measured in clinical trials.
Long-term clinical trial engagement is a behavioural challenge – not just an informational one
Explore why long-term clinical trial engagement is a behavioural challenge, showing how proactive support from site teams can help participants stay connected, confident and committed throughout a study.
Patients are telling the truth — just not to you
Patients are often most honest outside the clinic—revealing vital insights that can help clinical trial teams build trust, improve participation and collect better data.
When what matters to patients is hard to measure
Patient-relevant outcomes sit at the heart of the EU HTA reforms, but ensuring they reflect lived experience requires you to look beyond what traditional clinical endpoints measure.
Permission to pause: making treatment breaks part of the cancer care conversation
Exploring how empathetic, patient-centred communication can make planned treatment breaks easier to discuss as part of cancer care.
A seat at the table: what the EU HTA reforms really ask of patient involvement
The EU HTA reforms give patients a formal role in assessing new medicines, but meaningful involvement requires more than simply offering them a seat at the table.
Why faster trials make participant understanding more important than ever
As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain in a study.
Older trial participants reject bad design, not technology
Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences that make participation harder.
5 key takeaways from the Patient Centricity and Engagement Conference
Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful partnership can help turn patient engagement from intention into action.
It’s time to stop calling adverse events ‘manageable’
A single word—manageable—can minimise the real burden of treatment side effects, and it’s time clinical trial communication reflected patients’ lived experience more clearly.